Holen Sie sich die Stockscreener-App
175.61
0.53%
0.92
Handel nachbörslich:
175.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$174.69
Offen:
$174.8
24-Stunden-Volumen:
5.10M
Relative Volume:
5.04
Marktkapitalisierung:
$9.43B
Einnahmen:
$1.97B
Nettoeinkommen (Verlust:
$-494.50M
KGV:
-19.05
EPS:
-9.22
Netto-Cashflow:
$137.20M
1W Leistung:
+30.04%
1M Leistung:
+23.63%
6M Leistung:
+14.08%
1J Leistung:
-2.63%
1-Tages-Spanne:
$174.70
$175.80
1-Wochen-Bereich:
$129.21
$175.80
52-Wochen-Spanne:
$125.94
$194.88
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
175.61 | 9.38B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo CorporationMASI - FinancialContent
Danaher moves to acquire Masimo in $9.9bn deal - Life Sciences Intellectual Property Review
Danaher's Masimo Acquisition: Solid Financials, Conservative Growth Projections - Benzinga
Masimo (MASI) Downgraded by Wells Fargo with Lower Price Target - GuruFocus
Is It Too Late to Chase Masimo Stock on Major Danaher News? - Barchart.com
BofA Withdraws Rating on Masimo (MASI) Following Danaher Acquisi - GuruFocus
This Masimo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga
Danaher buys patient monitoring specialist Masimo in $9.9B deal - Fierce Biotech
Masimo (MASI) climbs 34% on $9.9-billion Danaher merger - MSN
Masimo (MASI) Climbs 34% on $9.9-Billion Danaher Merger - Insider Monkey
Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN
Danaher's Masimo Acquisition: Solid Financials, Conservative Growth Projections - Bitget
Danaher to Acquire Masimo in $9.9 Billion Deal to Expand Diagnostics Market - NTD News
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
3 Firms Advise On $9.9B Danaher, Masimo Diagnostics Deal - Law360
Danaher to Buy Masimo for $180 Per Share in All-Cash $9.9 Billion Transaction - PYMNTS.com
Masimo Q4 Earnings Release Signals Market Reaction - StocksToTrade
Masimo (NASDAQ:MASI) Shares Gap UpHere's Why - MarketBeat
Danaher Corp to acquire Masimo for $9.9B - respiratory-therapy.com
Market movers: Masimo Corporation, Norwegian Cruise Line Holdings, eToro, Paramount Skydance… - Proactive financial news
MASI Stock Alert: Halper Sadeh LLC is Investigating Whether Masimo Corporation is Obtaining a Fair Price for Its Shareholders - Business Wire
Danaher Corporation to Acquire Masimo Corporation - BOSS Publishing
Irvine’s Masimo selling to Danaher, Beckman Coulter owner, for $9.9 billion - Orange County Register
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Masimo Corporation (NASDAQ: MASI) - PR Newswire
Masimo: Danaher Acquisition Saves The Company From Lackluster Performance (NASDAQ:MASI) - Seeking Alpha
Danaher acquires Masimo for $9.9bn to bolster diagnostics business - Yahoo Finance
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Masimo Corporation( - GuruFocus
Danaher to acquire Masimo for $9.9 billion - The Business Journals
Masimo (MASI) Sees Significant 34% Surge in Stock Price - GuruFocus
Midday Stock Roundup: Masimo Jumps on Takeover News - Orange County Business Journal
Danaher to Acquire Masimo for $9.9B - Orange County Business Journal
Danaher Corporation entered into a definitive agreement to acquire Masimo Corporation from Politan Capital Management, L.P for $9.5 billion. - marketscreener.com
Danaher to buy Masimo for $9.9B - BioWorld MedTech
Masimo’s Financial Results Awaited, Market Braces for Insights - timothysykes.com
Danaher to buy Masimo for $10B - MassDevice
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
Masimo (MASI) Shares Jump Over 34% Following Significant Surge - GuruFocus
Danaher snaps up diagnostics firm Masimo for $10bn - Sharecast.com
Danaher (DHR) Stock Slides on $10B Masimo Buyout Announcement - Tokenist
Shares of Masimo, Danaher Moving on Acquisition Buzz - Bitget
Danaher agrees to buy Masimo for $9.9B - Modern Healthcare
Danaher Corporation (DHR) Announces Strategic Merger with Masimo - GuruFocus
Masimo shares jump 34% after Danaher agrees to buy the company for $180 per share in cash - Quiver Quantitative
Danaher Agrees to Buy Medical Tech Firm Masimo for $9.9 Billion - Bloomberg.com
Masimo jumps over 30% on report of potential $10 billion Danaher takeover - MSN
Masimo Preps for Q-Financal Reveal After Market Hours - StocksToTrade
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga
Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot - FinancialContent
Market news - investments.halifax.co.uk
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):